Cargando…
The Many Faces of Interleukin-6: The Role of IL-6 in Inflammation, Vasculopathy, and Fibrosis in Systemic Sclerosis
Interleukin-6 is currently attracting significant interest as a potential therapeutic target in systemic sclerosis (SSc). In this paper, the biology of interleukin-6 is reviewed, and the evidence for interleukin-6 dysregulation in SSc is explored. The role of inteleukin-6 classical and trans signall...
Autores principales: | Barnes, Theresa C., Anderson, Marina E., Moots, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176444/ https://www.ncbi.nlm.nih.gov/pubmed/21941555 http://dx.doi.org/10.1155/2011/721608 |
Ejemplares similares
-
Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?
por: Barnes, Theresa C, et al.
Publicado: (2010) -
DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models
por: Zhang, Zongwang, et al.
Publicado: (2019) -
Interleukin-6 Signaling Drives Fibrosis in Unresolved Inflammation
por: Fielding, Ceri A., et al.
Publicado: (2014) -
Role of interleukin 4 (IL4) and interleukin 6 (IL6) in the pathogenesis and prognosis of childhood primary immune thrombocytopenia
por: Zakaria, Marwa, et al.
Publicado: (2023) -
Role of interleukin-6 (IL-6) in predicting gestational diabetes mellitus
por: Amirian, Azam, et al.
Publicado: (2020)